USC-Brookings Schaeffer on Health Policy Balancing lower U.S. prescription drug prices and innovation – Part 1 Steven M. Lieberman, Paul B. Ginsburg, and Kavita Patel Tuesday, November 24, 2020
USC-Brookings Schaeffer on Health Policy Medicare payment for physician-administered (Part B) drugs Paul B. Ginsburg and Steven M. Lieberman Wednesday, February 10, 2021
Essay The FDA could do more to promote generic competition: Here’s how Rachel Sachs, Marta E. Wosińska, Richard G. Frank, and Loren Adler Tuesday, June 14, 2022
W TechStream Why can’t the Pentagon buy the cutting-edge technology it needs? Melanie W. Sisson Wednesday, February 23, 2022
Order from Chaos What the US and Canada can learn from other countries to combat the opioid crisis Keith Humphreys, Jonathan P. Caulkins, and Vanda Felbab-Brown Monday, January 13, 2020
FixGov If money can’t buy you votes, what can it buy? Lessons from Michael Bloomberg’s 2020 run Elaine Kamarck Thursday, March 5, 2020
Cities & Regions A community investment trust for Portland, Ore. residents to ‘buy back the block’ Reniya Dinkins October 14, 2020
Education Plus Development Creating playful learning spaces in cities: The important role of stakeholder buy-in Helen Shwe Hadani and Shwetha Parvathy Thursday, February 3, 2022
TechStream The ‘lying flat’ movement standing in the way of China’s innovation drive David Bandurski Thursday, July 8, 2021
Essay Government regulated or negotiated drug prices: Key design considerations Paul B. Ginsburg and Steven M. Lieberman Monday, August 30, 2021
TechTank Why Amazon is wrong about the American Innovation and Online Choice Act Bill Baer Tuesday, June 14, 2022
The Avenue Helping residents ‘buy back the block’ with American Rescue Plan funds Elwood Hopkins and Tracy Hadden Loh Tuesday, May 25, 2021
